CTSB and kidney disorder: In the study conducted by Piwowar et al., cathepsin B activity increased significantly (p < 0.001) in the urine of diabetic patients as compared to the control group, and they concluded that it may be useful as a non-invasive surrogate marker of incipient nephropathy [33].